AI assistant
Sending…
Medtronic plc — Director's Dealing 2016
Mar 17, 2016
29841_dirs_2016-03-17_e5beca3c-c3cf-4897-9a59-46c190ab286c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2016-03-15
Reporting Person: ISHRAK OMAR (Director, Chairman & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-03-15 | Ordinary Shares | M | 323013 | $34.88 | Acquired | 854272 | Direct |
| 2016-03-15 | Ordinary Shares | F | 229735 | $76.85 | Disposed | 624537 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-03-15 | Stock Option (Right to Buy) | $34.88 | M | 323013 | Disposed | 2021-08-24 | Ordinary Shares (323013) | Direct |
Footnotes
F1: This balance increased by 4435 shares due to exempt transactions such as dividend reinvestment.
F2: This option was exercised under a 10b5-1 plan.
F3: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
More from Medtronic plc
Report Publication Announcement
2026
Jun 3
Regulatory Filings
2026
May 28
Board/Management Information
2026
May 18
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Feb 26
Director's Dealing
2026
Feb 24
Interim / Quarterly Report
2026
Feb 24
Earnings Release
2026
Feb 17
Director's Dealing
2026
Feb 2
Director's Dealing
2026
Jan 29